About EEP
Investment Orientation
The Team




Investor Reporting
Contact Us
Site Map
Terms & Conditions

EEP News

CMC Biologics Participates in Denmark State Visit to Korea

2nd November 2016

CMC Biologics Copenhagen Facility site head Patricio Massera, was honored to participate in the recent Danish State Visit to Korea

CMC visit South Korea

CMC Biologics was chosen for inclusion in the state visit, along with representatives from other select Danish companies in the Health Industry, for participation in a Denmark- Korea Roundtable Meeting on Health.

The state visit included Danish Prime Minister Lars Løkke Rasmussen, the Danish Health Minister, other politicians from Denmark and South Korea, and selected participants from Danish health companies. This was the first official visit of a Danish Prime Minister to South Korea in 25 years.
Patricio Massera is shown in the accompanying photograph. He is standing in the back row, fifth from the left. Lars Løkke Rasmussen is seated in the front row, fourth from the left.

About CMC Biologics
CMC Biologics is leading the industry among CMOs in customer satisfaction, technical excellence, and quality – Right and On Time. With three facilities in the USA and Europe, the Company provides fully integrated biopharmaceutical development and manufacturing solutions to clients globally. The Company has proven expertise in delivering custom solutions for the scale-up and cGMP manufacture of protein-based therapeutics for pre-clinical, clinical trials and commercial production. The Company's wide range of integrated services includes cell line development, bioprocess development, formulation and comprehensive analytical testing. Clients can also benefit from CMC Biologics' proprietary CHEF1®expression system for mammalian production. More detailed information can be found at www.cmcbiologics.com.


Back to News

EEP Advisers Limited is Authorised and Regulated by the Financial Conduct Authority